In vitro study of cell-promoting multiple-armed peptides.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Surface Chemistry

Background:

• Prosthetic vascular grafts require surfaces that promote cell integration and growth.
• Cell-binding peptides are investigated for their potential to enhance graft biocompatibility.
• Optimizing peptide structure is crucial for maximizing cell response.

Purpose of the Study:

• To compare the efficacy of linear and branched cell-binding peptides in promoting cell growth on expanded polytetrafluoroethylene (ePTFE) vascular grafts.
• To evaluate the impact of immobilized peptides on endothelial and smooth muscle cell behavior.

Main Methods:

• Covalent immobilization of linear (P15) and branched (MAP4) peptides onto ePTFE grafts via atmospheric plasma coating.
• Surface characterization using X-ray photoelectron spectroscopy and amino acid analysis.
• In vitro assessment of human umbilical vein endothelial cell (HUVEC) and human umbilical artery smooth muscle cell (HUASMC) adhesion, proliferation, and morphology.

Main Results:

• Branched MAP4 peptides significantly outperformed linear P15 peptides in promoting HUVEC proliferation (800% increase vs. control).
• MAP4 peptides showed 80% greater HUVEC promotion compared to P15 peptides.
• MAP4 peptides were less effective for HUASMC promotion compared to HUVECs, with only a 100% increase vs. control, similar to P15 peptides for SMCs.

Conclusions:

• Branched MAP4 peptides are superior to linear P15 peptides for promoting endothelial cell growth on ePTFE vascular grafts.
• The differential cell response highlights the importance of peptide architecture in biomaterial design.
• These findings offer insights for developing next-generation vascular grafts with enhanced endothelialization.